Response to Carlson

Erica M Bednar^{1

2}, Charlotte C Sun³, Sheryl McCurdy⁴, Sally W Vernon⁴

Affiliations

¹ Clinical Cancer Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. embednar@mdanderson.org.
² Cancer Prevention and Control Platform, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. embednar@mdanderson.org.
³ Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁴ Department of Health Promotion and Behavioral Sciences, The University of Texas Health Science Center at Houston School of Public Health, Houston, TX, USA.

Free article

Comment

Erica M Bednar et al. Genet Med. 2021 Jun.

Free article

. 2021 Jun;23(6):1169-1170.

doi: 10.1038/s41436-020-01095-5. Epub 2021 Mar 23.

Erica M Bednar^{1

2}, Charlotte C Sun³, Sheryl McCurdy⁴, Sally W Vernon⁴

¹ Clinical Cancer Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. embednar@mdanderson.org.
² Cancer Prevention and Control Platform, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. embednar@mdanderson.org.
³ Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁴ Department of Health Promotion and Behavioral Sciences, The University of Texas Health Science Center at Houston School of Public Health, Houston, TX, USA.

No abstract available

Comment on

Assessing relatives' readiness for hereditary cancer cascade genetic testing.
Bednar EM, Sun CC, McCurdy S, Vernon SW. Bednar EM, et al. Genet Med. 2020 Apr;22(4):719-726. doi: 10.1038/s41436-019-0735-3. Epub 2019 Dec 20. Genet Med. 2020. PMID: 31857708
Correspondence on "Assessing relatives' readiness for hereditary cancer cascade genetic testing" by Bednar et al.
Carlson J. Carlson J. Genet Med. 2021 Jun;23(6):1167-1168. doi: 10.1038/s41436-020-01094-6. Epub 2021 Mar 19. Genet Med. 2021. PMID: 33742172 No abstract available.

1. Carlson, J. Correspondence on “Assessing relatives’ readiness for hereditary cancer cascade genetic testing” by Bednar et. al. Genet. Med. (in press) (2020).
1. Bednar, E. M., Sun, C. C., McCurdy, S. & Vernon, S. W. Assessing relatives’ readiness for hereditary cancer cascade genetic testing. Genet. Med. 22, 719–726 (2019).
1. Rayes, N. et al. MAGENTA (making genetic testing accessible): a prospective randomized controlled trial comparing online genetic education and telephone genetic counseling for hereditary cancer genetic testing. BMC Cancer 19, 648 (2019). - DOI
1. Himes, D. O. et al. Female family members lack understanding of indeterminate negative BRCA1/2 test results shared by probands. J. Genet. Couns. 28, 950–961 (2019). - DOI
1. Prochaska, J. O., Redding, C. A. & Evers, K. E. The transtheoretical model and stages of change. In Health Behavior: Theory, Research, and Practice (eds. Glanz, B., Rimer, B. K. & Viswanath, K.) 125 (Jossey-Bass, San Francisco, 2015).